Literature DB >> 18030213

Cryptosporidium infection in patients with primary immunodeficiencies.

Beata Wolska-Kusnierz1, Anna Bajer, Simone Caccio, Edyta Heropolitanska-Pliszka, Ewa Bernatowska, Piotr Socha, Jacques van Dongen, Malgorzata Bednarska, Anna Paziewska, Edward Sinski.   

Abstract

BACKGROUND: Cryptosporidium species infection is usually self-limited in immunocompetent populations, but can be severe and life-threatening among immunocompromised individuals, particularly in patients with AIDS and in these patients with primary immunodeficiencies (PIDs). PATIENTS AND METHODS: A group of 5 patients with genetically confirmed hyper-IgM syndrome type 1 (XHIM) and one patient with primary CD4 lymphopenia were enrolled in the study. At least 2 stool samples and a bile sample in one patient were examined for Cryptosporidium oocysts by a modified Ziehl-Neelsen technique, by immunofluorescence assay using a commercial kit, as well as by molecular analysis followed by genotyping. Immunological status at the time of PID diagnosis and the complex picture of disease are presented.
RESULTS: Chronic cryptosporidiosis was confirmed in 3 patients with XHIM and in one patient with primary CD4 lymphopenia. Molecular diagnosis showed the presence of C parvum, C hominis, and C meleagridis in analyzed specimens.
CONCLUSIONS: Cryptosporidium infection with serious clinical symptoms observed in patients with hyper-IgM syndrome calls for regular, repeated screening in this group of patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18030213     DOI: 10.1097/MPG.0b013e318054b09b

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  19 in total

1.  Putative cis-regulatory elements associated with heat shock genes activated during excystation of Cryptosporidium parvum.

Authors:  Benjamin Cohn; Patricio Manque; Ana M Lara; Myrna Serrano; Nihar Sheth; Gregory Buck
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

Review 2.  Human immune responses in cryptosporidiosis.

Authors:  Anoli Borad; Honorine Ward
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

Review 3.  Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review.

Authors:  M Teresa de la Morena; Robert P Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

Review 4.  Cryptosporidium pathogenicity and virulence.

Authors:  Maha Bouzid; Paul R Hunter; Rachel M Chalmers; Kevin M Tyler
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

Review 5.  Cryptosporidium and Giardia spp. infections in humans, animals and the environment in Poland.

Authors:  Anna Bajer
Journal:  Parasitol Res       Date:  2008-09-13       Impact factor: 2.289

Review 6.  Clinical significance of enteric protozoa in the immunosuppressed human population.

Authors:  D Stark; J L N Barratt; S van Hal; D Marriott; J Harkness; J T Ellis
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

7.  Genotyping of Cryptosporidium isolates from human clinical cases in Poland.

Authors:  Anna Bajer; Małgorzata Bednarska; Simone M Cacciò; Beata Wolska-Kuśnierz; Edyta Heropolitanska-Pliszka; Ewa Bernatowska; Małgorzata Wielopolska; Anna Paziewska; Renata Welc-faleciak; Edward Siński
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

8.  Cryptosporidiosis-an overview.

Authors:  Gordon J Leitch; Qing He
Journal:  J Biomed Res       Date:  2012-02-21

9.  Global distribution, public health and clinical impact of the protozoan pathogen cryptosporidium.

Authors:  Lorenza Putignani; Donato Menichella
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-07-14

10.  Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome.

Authors:  Daniel Kotlarz; Natalia Ziętara; Gulbu Uzel; Thomas Weidemann; Christian J Braun; Jana Diestelhorst; Peter M Krawitz; Peter N Robinson; Jochen Hecht; Jacek Puchałka; E Michael Gertz; Alejandro A Schäffer; Monica G Lawrence; Lela Kardava; Dietmar Pfeifer; Ulrich Baumann; Eva-Doreen Pfister; Eric P Hanson; Axel Schambach; Roland Jacobs; Hans Kreipe; Susan Moir; Joshua D Milner; Petra Schwille; Stefan Mundlos; Christoph Klein
Journal:  J Exp Med       Date:  2013-02-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.